Bright Minds Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRUG and other ETFs, options, and stocks.

About DRUG

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. 

CEO
Ian B. McDonald
CEOIan B. McDonald
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2019
Founded2019
Employees
Employees

DRUG Key Statistics

Market cap
619.27M
Market cap619.27M
Price-Earnings ratio
-83.34
Price-Earnings ratio-83.34
Dividend yield
Dividend yield
Average volume
160.39K
Average volume160.39K
High today
High today
Low today
Low today
Open price
$84.79
Open price$84.79
Volume
0.00
Volume0.00
52 Week high
$97.75
52 Week high$97.75
52 Week low
$23.18
52 Week low$23.18

Stock Snapshot

The current Bright Minds Biosciences(DRUG) stock price is $78.88, with a market capitalization of 619.27M. The stock trades at a price-to-earnings (P/E) ratio of -83.34.

On 2025-12-19, Bright Minds Biosciences(DRUG) shares started trading at $84.79, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 160.39K.

The stock's 52-week range extends from a low of $23.18 to a high of $97.75.

The stock's 52-week range extends from a low of $23.18 to a high of $97.75.

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own DRUG. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.